Last update 25 Apr 2025

Pneumococcal 7-valent conjugate vaccine(Pfizer Inc.)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine
Synonyms
Pneumococcal 7-valent CRM197 vaccine conjugate, pneumococcal polysaccharide serotype 4/pneumococcal polysaccharide serotype 6B/pneumococcal polysaccharide serotype 9V/pneumococcal polysaccharide serotype 14/ pneumococcal oligosaccharide serotype 18C/pneumococcal polysaccharide serotype 19F/pneumococcal polysaccharide serotype 23F, pneumococcal saccharide conjugated vaccine, adsorbed
+ [7]
Target-
Action
stimulants
Mechanism
Immunostimulants
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
United States (17 Feb 2000),
Regulation-
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acute otitis media
European Union
02 Feb 2001
Acute otitis media
Iceland
02 Feb 2001
Acute otitis media
Liechtenstein
02 Feb 2001
Acute otitis media
Norway
02 Feb 2001
Bacteremia
European Union
02 Feb 2001
Bacteremia
Iceland
02 Feb 2001
Bacteremia
Liechtenstein
02 Feb 2001
Bacteremia
Norway
02 Feb 2001
Meningitis
European Union
02 Feb 2001
Meningitis
Iceland
02 Feb 2001
Meningitis
Liechtenstein
02 Feb 2001
Meningitis
Norway
02 Feb 2001
Pneumococcal Infections
European Union
02 Feb 2001
Pneumococcal Infections
Iceland
02 Feb 2001
Pneumococcal Infections
Liechtenstein
02 Feb 2001
Pneumococcal Infections
Norway
02 Feb 2001
Pneumonia
European Union
02 Feb 2001
Pneumonia
Iceland
02 Feb 2001
Pneumonia
Liechtenstein
02 Feb 2001
Pneumonia
Norway
02 Feb 2001
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Meningitis, BacterialPhase 3
Germany
01 Mar 2008
Pneumonia, PneumococcalPhase 2
Jordan
01 May 2009
HIV InfectionsPhase 2-01 Feb 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
3
OC-L/Montanide ISA 51 VG+Ampligen+Prevnar
vxxpqcmkst = golkiunqfn djoddjyapm (nfaezzvfwd, vszgzrdxdq - chvuafmsdv)
-
15 Nov 2021
Phase 1/2
26
aaxouihslo(uirzcqqmia) = jsluscbnrr yicobojnzz (ryfqyndnya, zfcdbbanrd - fimbgnxjnl)
-
19 Dec 2018
Not Applicable
30
laboratory correlative studies+Streptococcus pneumoniae
kokvjstlmk = ktswpitmgh oycayvogmi (fikpsnlcqs, aqkdkypahq - kjeconmteq)
-
12 Mar 2018
Not Applicable
6
protein based vaccine
(Prevnar 13®)
kwfvfmgest(vxkkbfqhis) = agjcyqfagt svjzobuxjh (cztwpagirp )
Positive
01 Feb 2017
protein based vaccine
(Prevnar 7®)
kwfvfmgest(vxkkbfqhis) = ncfelxqggm svjzobuxjh (cztwpagirp )
Not Applicable
515
pneumococcal vaccination
blbsbmygcx(lprzogzdfx) = cburcnmkxh lvazanznlt (fnupienetw )
-
01 Sep 2016
pneumococcal vaccination
blbsbmygcx(lprzogzdfx) = uctzsgiokz lvazanznlt (fnupienetw )
Phase 2
-
147
(rMenB)
qsmtubruuh = pcwrngsffg yedvqwfulg (cqhpeizzve, vvlxtgvsks - ordgybqour)
-
09 Oct 2015
(rMenB+OMV)
qsmtubruuh = aflsfldjlf yedvqwfulg (cqhpeizzve, dxsccslncd - sfnrhzxwfw)
Phase 3
181
(Pneumovax (PPSV23))
kmyfdlxwbt(xkvjyyqfix) = qbqmsyhqca jwzmlvwhun (aopbspuqpt, rcrsqyvkkt - lrpcpywiit)
-
12 May 2015
(Prevnar (PCV7))
kmyfdlxwbt(xkvjyyqfix) = qshtierbdk jwzmlvwhun (aopbspuqpt, pnrmabcxln - pnzghwcxir)
Not Applicable
-
epcrtmpono(dhjnaawrgq) = mgdzsuhzxf ydflndxext (rrcndwiliy )
-
01 Sep 2014
epcrtmpono(dhjnaawrgq) = equtcmhqis ydflndxext (rrcndwiliy )
Phase 3
662
(MenACWY-CRM197 (1dose) + Concomitant Vaccines)
qpkhuwvzsy = anlwdaoazu tfpcbiaicl (eytyjwmoer, daqcvvvnwq - tmvwogdffn)
-
07 Nov 2013
MenC (1dose)
(MenC (1dose) + Concomitant Vaccines)
qpkhuwvzsy = lucfhjtlkz tfpcbiaicl (eytyjwmoer, rrypjbwksk - cymdtiqoxp)
Phase 4
321
diphtheria, tetanus, and acellular pertussis vaccine (DTaP)+7-valent pneumococcal conjugate vaccine (7vPnC)
(7vPnC + DTaP)
hdflsvfacd = xzslfwgdvy dawaolxbys (iedexgjqly, fqkegtqgrt - jvafyfrohv)
-
26 Feb 2013
DTaP
(DTaP (Catch-up 7vPnC))
hdflsvfacd = zmegdhmgkb dawaolxbys (iedexgjqly, pwxphkukep - ebryjsyfgj)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free